News & Publications
Stanford Medicine News: Cancer
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Two novel Stanford studies have uncovered attributes of high-quality, low-cost care for cancer and primary care patients.
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
Stanford is one of four institutions to receive National Cancer Institute funding to analyze patients’ immune function and tumor profiles as part of a public-private partnership to accelerate cancer therapies.
A quarterly publication for patients and friends of the Stanford Cancer Institute.
A monthly publication with timely information for the cancer researchers, physicians and staff who make up the membership of the Stanford Cancer Institute.
MD Community Newsletter
This quarterly publication is designed to inform our colleagues in the medical community, and especially physicians who are considering treatment options for their patients with cancer, about current clinical trials and research studies available at the NCI-designated Stanford Cancer Institute.
A publication for our community physicians, Stanford Access offers you a look into the programs and faculty of Stanford Health Care. Learn about the latest diagnostics, treatment solutions and innovative procedures happening at Stanford.